Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Kvanta

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Acta Ophthalmologica|August 30, 2008
Neovascular age-related macular degeneration: too many theories, too little knowledge?Anders Kvanta
Acta Ophthalmologica Scandinavica|January 25, 2007
New treatments for neovascular age-related macular degeneration: when should we use them?Anders Kvanta
Acta Ophthalmologica Scandinavica|May 18, 2006
Ocular angiogenesis: the role of growth factorsAnders Kvanta
Acta Ophthalmologica|July 30, 2013
Stem cell-based treatment in geographic atrophy: promises and pitfallsAnders Kvanta, Monika K Grudzinska
Current Eye Research|September 13, 2006
Photodynamic therapy of experimental choroidal neovascularization in the mouseAnne Odergren, Yue Ming, Anders Kvanta
Acta Ophthalmologica|May 24, 2008
Shall we use Avastin or Lucentis for ocular neovascularization?Peep V Algvere, Anders Kvanta, Stefan Seregard
Current Eye Research|June 28, 2016
Vitamin D Deficiency in Patients with Central Retinal Vein Occlusion: A Case Control StudyDavid Epstein, Anders Kvanta, Pelle G Lindqvist
Ophthalmic Epidemiology|March 18, 2015
Seasonality and incidence of central retinal vein occlusion in Sweden: a 6-year studyDavid Epstein, Anders Kvanta, Pelle G Lindqvist
Acta Ophthalmologica|March 25, 2016
Drusen maculopathy: a risk factor for visual deteriorationPeep V Algvere, Anders Kvanta, Stefan Seregard
Acta Ophthalmologica|June 4, 2016
Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesisParviz Mammadzada, Johann Gudmundsson, Anders Kvanta, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Acta Ophthalmologica|August 30, 2008
Neovascular age-related macular degeneration: too many theories, too little knowledge?Anders Kvanta
Acta Ophthalmologica Scandinavica|January 25, 2007
New treatments for neovascular age-related macular degeneration: when should we use them?Anders Kvanta
Acta Ophthalmologica Scandinavica|May 18, 2006
Ocular angiogenesis: the role of growth factorsAnders Kvanta
Acta Ophthalmologica|July 30, 2013
Stem cell-based treatment in geographic atrophy: promises and pitfallsAnders Kvanta, Monika K Grudzinska
Current Eye Research|September 13, 2006
Photodynamic therapy of experimental choroidal neovascularization in the mouseAnne Odergren, Yue Ming, Anders Kvanta
Acta Ophthalmologica|May 24, 2008
Shall we use Avastin or Lucentis for ocular neovascularization?Peep V Algvere, Anders Kvanta, Stefan Seregard
Current Eye Research|June 28, 2016
Vitamin D Deficiency in Patients with Central Retinal Vein Occlusion: A Case Control StudyDavid Epstein, Anders Kvanta, Pelle G Lindqvist
Ophthalmic Epidemiology|March 18, 2015
Seasonality and incidence of central retinal vein occlusion in Sweden: a 6-year studyDavid Epstein, Anders Kvanta, Pelle G Lindqvist
Acta Ophthalmologica|March 25, 2016
Drusen maculopathy: a risk factor for visual deteriorationPeep V Algvere, Anders Kvanta, Stefan Seregard
Acta Ophthalmologica|June 4, 2016
Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesisParviz Mammadzada, Johann Gudmundsson, Anders Kvanta, et al.
Pageof 8